Financhill
Sell
39

CC Quote, Financials, Valuation and Earnings

Last price:
$12.53
Seasonality move :
-0.08%
Day range:
$12.46 - $13.06
52-week range:
$9.13 - $22.27
Dividend yield:
4.09%
P/E ratio:
66.47x
P/S ratio:
0.32x
P/B ratio:
6.31x
Volume:
2.2M
Avg. volume:
2.9M
1-year change:
-41.07%
Market cap:
$1.9B
Revenue:
$5.8B
EPS (TTM):
-$2.22

Analysts' Opinion

  • Consensus Rating
    The Chemours Co. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $15.78, The Chemours Co. has an estimated upside of 25.82% from its current price of $12.54.
  • Price Target Downside
    According to analysts, the lowest downside price target is $13.00 representing -3.67% downside risk from its current price of $12.54.

Fair Value

  • According to the consensus of 8 analysts, The Chemours Co. has 25.82% upside to fair value with a price target of $15.78 per share.

CC vs. S&P 500

  • Over the past 5 trading days, The Chemours Co. has overperformed the S&P 500 by 0.44% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • The Chemours Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • The Chemours Co. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Chemours Co. reported revenues of $1.5B.

Earnings Growth

  • The Chemours Co. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter The Chemours Co. reported earnings per share of $0.40.
Enterprise value:
5.7B
EV / Invested capital:
1.21x
Price / LTM sales:
0.32x
EV / EBIT:
15.08x
EV / Revenue:
0.97x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-473.64x
Price / Operating cash flow:
432.03x
Enterprise value / EBITDA:
7.96x
Gross Profit (TTM):
$1B
Return On Assets:
-4.44%
Net Income Margin (TTM):
-5.65%
Return On Equity:
-69.66%
Return On Invested Capital:
-6.85%
Operating Margin:
6.56%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $6B $5.8B $5.9B $1.5B $1.5B
Gross Profit $1.3B $1.1B $1B $287M $231M
Operating Income -$78M $378M $377M $124M $98M
EBITDA $229M $675M $714M $202M $178M
Diluted EPS -$2.13 $0.42 -$2.22 -$0.21 $0.40
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $3.4B $3.5B $3.7B $3.1B $3.2B
Total Assets $7.5B $7.7B $7.9B $7.5B $7.6B
Current Liabilities $1.8B $2B $2.2B $1.8B $1.9B
Total Liabilities $6.5B $6.5B $7.2B $6.8B $7.3B
Total Equity $999M $1.3B $757M $659M $300M
Total Debt $4.1B $3.7B $4.2B $4.2B $4.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $235M -$289M $265M $139M $146M
Cash From Investing -$164M -$376M -$270M -$75M -$35M
Cash From Financing -$14M -$126M -$4M -$27M -$5M
Free Cash Flow -$67M -$675M -$12M $63M $105M
CC
Sector
Market Cap
$1.9B
$20.8M
Price % of 52-Week High
56.32%
70.43%
Dividend Yield
4.09%
0%
Shareholder Yield
2.71%
-2.49%
1-Year Price Total Return
-41.07%
5.89%
Beta (5-Year)
1.593
0.622
Dividend yield:
4.09%
Annualized payout:
$1.00
Payout ratio:
21.99%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $12.52
200-day SMA
Sell
Level $13.21
Bollinger Bands (100)
Sell
Level 12.27 - 15.71
Chaikin Money Flow
Sell
Level -13.3M
20-day SMA
Buy
Level $12.05
Relative Strength Index (RSI14)
Buy
Level 50.11
ADX Line
Sell
Level 22.8
Williams %R
Neutral
Level -21.3483
50-day SMA
Sell
Level $13.31
MACD (12, 26)
Sell
Level -0.14
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 2.5M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7051)
Sell
CA Score (Annual)
Level (-1.8205)
Sell
Beneish M-Score (Annual)
Level (-1.6074)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.0877)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014 and is headquartered in Wilmington, DE.

Stock Forecast FAQ

In the current month, CC has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CC average analyst price target in the past 3 months is $15.78.

  • Where Will The Chemours Co. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that The Chemours Co. share price will rise to $15.78 per share over the next 12 months.

  • What Do Analysts Say About The Chemours Co.?

    Analysts are divided on their view about The Chemours Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Chemours Co. is a Sell and believe this share price will drop from its current level to $13.00.

  • What Is The Chemours Co.'s Price Target?

    The price target for The Chemours Co. over the next 1-year time period is forecast to be $15.78 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is CC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for The Chemours Co. is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of CC?

    You can purchase shares of The Chemours Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Chemours Co. shares.

  • What Is The The Chemours Co. Share Price Today?

    The Chemours Co. was last trading at $12.53 per share. This represents the most recent stock quote for The Chemours Co.. Yesterday, The Chemours Co. closed at $12.54 per share.

  • How To Buy The Chemours Co. Stock Online?

    In order to purchase The Chemours Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock